Outpatient use of musculoskeletal drugs in Zagreb in 2001 (CROSBI ID 507909)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Štimac, Danijela ; Vukušić, Ivan ; Čulig, Josip ; Polić-Vižintin, Marina ; Leppee, Marcel
engleski
Outpatient use of musculoskeletal drugs in Zagreb in 2001
Objective: To analyse the use of drugs acting on the musculoskeletal system in Zagreb in 2001 based on ATC and DDD drug classification system by WHO. Method: The data on outpatient musculoskeletal drug use (group M) were obtained from 31 pharmacy units of Zagreb Pharmacies Group. The data were extrapolated on the total number of pharmacies in Zagreb and DDD and DDD per thousand inhabitants per day(DDD/TID)were calculated. The number and type of drugs accounting for 90% of total use of group M drugs (DU90%) was also defined. Results: The total number of DDD/TID for group M amounts to 104.9, while drugs pertaining to M01 subgroup (antiinflammatory and antirheumatic drugs)are used to the greatest extent, i.e. with 94.9 DDD/TID. The group comprising 90% of the use, i.e. the DU90% contains 5 drugs of the total of 19 drugs participating in outpatient use. Diclofenac sodium accounts for more than 50% of drugs in the DU90% segment(47.3 DDD/TID). Conclusion: The therapeutic group of non-steroid antirheumatic drugs accounts for 90% of the total use, with diclofenac sodium making more than 50% of these.
Musculoskeletal drugs; outpatient use; ATC/DDD methodology; Zagreb
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2004.
objavljeno
Podaci o matičnoj publikaciji
Devor, M., Erdine, S., and Ruiz-Lopez, R.
Barcelona:
Podaci o skupu
3rd World Congress World Institute of Pain
poster
21.09.2004-25.09.2004
Barcelona, Španjolska